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Mortality of cadmium-exposed workers
A five-year update
by George Kazantzis , FRCP, FFOM,1 Tai-Hing Lam, MSc, MFOM,1.2 Keith R Sullivan, MSc,
AFIMA 1
KAZANTZIS G, LAM T-H , SULLIVAN KR. Mortality of cadmium-exposed workers: A five-year up-
date . Scand J Work Environ Health 14 (1988)220-223. A cohort mortal ity study of cadmium-exposed
workers initially followed to the end of 1979has been updated for a furth er five years. The update has
confirmed the findings of the original study with a significant excess risk from bronchitis related to inten-
sity of exposure, although over the five-year period the excessmortality was no longer significant, a finding
suggesting that the risk from bronchitis may now be declining in this cohort. In contrast, there is now
a stronger indication of an excess risk from lung cancer related to intensity of exposure, significant for
both the total and the five-year periods . There was again no increased risk from prostatic cancer, and
from this and other studies it appears unlikely that cadmium, in the concentra tions encountered in this
and other recent studies, acts as a prostatic carcinogen. As in the initial study, there was no significant
excess risk from hyperten sive disease, nor any suggestion of an increased risk from cerebrovascular or
renal disease.
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The International Register of Potentially Toxic
Chemicals (lRPTC) of the United Nations Environ-
ment Programme (UNEP) includes cadmium in its
listing of environmentally dangerous chemical
substances and processes of global significance (11).
Atmospheric emissions of cadmium from man-made
sources are considered in the IRPTC to exceed those
of natural origin by one order of magnitude. Cigarette
smokers were observed to be potentially at risk because
of the high absorption of cadmium from tobacco
smoke. Certain compounds of cadmium have been
shown to give rise to cancer in animal studies (5), but
the role of cadmium as a human carcinogen remains
uncertain. The International Agency for Research on
Cancer (IARC) in 1982considered the evidence for the
carcinogenicity of cadmium to be sufficient in animals ,
but limited in humans (3). Their classification of cad-
mium at that time as a 2B carcinogen was proposed
for reclassification to category 2A in 1987.
The study of groups with occupational exposure is
of particular value in elucidating adverse effects, as
not only is exposure likely to have been greater in the
occupational than in the general environment, but also
absorption is markedly more effective following the
inhalation of cadmium oxide fume and cadmium-
containing dusts than after the ingestion of cadmium
in food or water. A cohort of almost 7 000 male
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workers born before 1940and exposed to cadmium for
more than one year between 1942and 1970was initially
followed with regard to mortality experience to the end
of 1979(1,4). A statistically significant excess of deaths
recorded as bronchitis was related to both intensity and
duration of exposure, predominantly in the small
group of men with heavy past exposure to cadmium.
There were marginally more deaths from lung cancer
than expected, but the excess was not related to ex-
posure levels. No excess of deaths due to prostatic
cancer, cerebrovascular disease, or renal diseases and
no significant excess due to emphysema or hyperten-
sive disease were observed. This cohort stud y has now
been updated for a further five years to include all
deaths to the end of 1984.
Material and methods
Details of the methods used for the cohort analysis
have been given earlier (1) and are briefly summarized
here. Deaths were coded by underlying and other
causes according to the eighth revision of the Interna-
tional Classification of Diseases (lCD) (13). Expected
numbers were calculated from mortality rates for the
population of England and Wales corrected to the
eighth revision ICD codes, and regional variation in
mortality was taken into account by the use of the
cause-specific standardized mortality ratio (SMR) for
standard regions published by the Office of Popula-
tion Censuses and Surveys for the period 1969-1973.
The ratios of observed to expected deaths (SMR values)
were calculated, in five-year age and calendar strata,
with the use of the Oxford Man-year Program devised
Table 1. Cau se-specifi c mortality in re lation to cadmium ex posure (19 43-1984). (0 = observed cases, E =expected cases,
SMR= standard ized mortality ratio, 95 % CI = confidence interval)
Exposure to cadmium
Disease (ICD) Ever high Ever medium Always low Total
0 E SMR 95 % CI 0 E SMR 95% CI 0 E SMR 95 % CI 0 E SMR 95 % CI
All causes 60 56.3 107 60-133 319 328.2 97 67-106 2 088 21 19.0 99 94- 103 2 467 2504.3 99 95- 102
All neoplasms
(140-239) 22 14.7 150 94 - 227 86 84.6 101 60-123 579 523.5 111 102- 120 687 623.1 110 102- 118
Lung cancer (162) 12 6.2 194 100-339 41 34.0 121 84- 158 224 200.7 112 97-126 277 240.9 115 101-129
Stomach cancer (151) 3 1.6 189 39-553 12 9.1 131 68-230 83 59.8 139 109-169 98 70.6 139 111-166
Prostate cancer (185) 0.6 0 0-615 4.0 0 0-92 30 28.6 105 71-150 30 33.2 90 61-129
Hypertensive diseases
(400-404) 0.8 124 3-692 8 4.8 168 72-331 40 35.7 112 77- 147 49 41.3 119 85-152
Cerebrovascular
diseases (430-438) 2 4.8 42 5-151 23 29.0 79 50-119 153 196.5 78 66-90 178 230.3 77 66-89
Bronchiti s (490-491) 13 3.4 382 203-654 25 17.1 146 94-215 140 114.3 123 102-143 178 134.9 132 113-151
Emphysema (492) 0.2 0 0-1 85 1.3 0 0-264 16 9.2 174 99- 282 16 10.8 149 85-241
Nephritis and nephrosis
(580-584) 0.4 258 7-1437 2.2 45 1-248 14 16.2 86 47- 145 16 18.9 85 49-138
by J Peto in 1980, the 95 lIlo con fidence interval (95 %
CI) of the SMR being used to indicate statistical sig-
nificance.
In addition to the seven disease categories for which
there was some a pr iori -reason to believe that a rela-
tion ship to cadmium exposure might exist , stomach
cancer was now included for detailed anal ysis becau se
an excess mortality had been ob served in a reanalysis
of the 1979 data (6). Thus eight categories, together
with "all causes" and "all neoplasms," have been in-
cluded in the present repo rt. Deaths occurr ing in these
10 catego ries have been followed to the age of 85 years.
For a further 32 disease categories a screening pro-
cedure has been used with a censoring age of 75 years.
Jobs were again classified according to the level of
past cadmium expo sure into the three groups high ,
medium and low , and the years at risk were divided
on the basis of the se categories into th e three groups
" ever high " for a minim um period of one year, " ever
medium" for a min imum period of one year, and
" always low." For those wor kers who were still
employed after 1979, the ir employment status between
1980-1984 was updated .
Rescrutiny of the initial study population identified
a small number of erroneous entries, which reduced
the number of workers included in the SMR analysis
from 6 995 to 6 958 for the five-year period. The mean
duration of expo sur e to cadmium was 12 years, and
the mean interval fro m first exposure to the end of
follow-up was 29 years. The distr ibution of the workers
in the five principal industries involved was as in the
initial study. By the end of 1984, 2 523 (36 % of the
study populat ion) had died; 4 184 (60 %) were kno wn
to be alive; 184 (3 %) had emigrated; and 67 (l %)
could not be traced . Th e reported tabulations refe r to
2 467 deced ents below the age of 85 years. The five
years 1980- 1984 gave an extra 21 857 per son- years
to the study with a to tal now of 173 961 per son- years
for the period 1943-1984.
Results
Cause-specific mortality in rela tion to cadmium ex-
po sure for the total study per iod is shown in table 1.
With the additional five years of follow-up, all-cause
mortality remained virtually unchanged . All- cause
mortality increased with length of follow-up, being sig-
nificantly lower than expected for those follo wed for
less than 10 years (SMR 79, 95 % CI 68-90) and
significantly higher than expected for those followed
for more than 30 years (SMR 139, 95 % CI 104-174),
a finding in keeping with the commonly obs erved
" healthy worker effect. "
Over the five-year period there were 26 deaths coded
as bronchitis or chronic bronchitis, this level ind icating
a nons ignificant excess (SMR 132, 95 % CI 86-194)
which was not related to intensity of exposure.
However over the total study period the excess mor-
tality from bronchitis was highly significant (SMR 132,
95 % CI 113-151), pa rt icularly in the small high-
expo sure group (SMR 382, 95 % CI 203- 654). There
was a small but sign ificant number of deaths from
emphysema over the five-year period, all from the low-
exposure group (SMR 277, 95 % CI 102-603) which,
for the total study period, approached a significant
level, aga in all in the low-expo sure group (SMR 174,
95 % CI 99-282).
Morta lity from all neoplastic disorders was
significantly raised for both the five-year and the total
study period (SMR 124,95 % CI 106-142 and SMR
110,95 % CI 102-118, respectively), attributed main-
ly to an increase in lung and stomach cancer mortali-
ty . Th e SMR for prostatic cancer had fallen from 99
in the 1979 cohort to 90 in the total study period , with
30 observed deaths in the low-exposur e group and
again no deaths in the medium- or high-exposure
categories.
The five-year update contributed 75 additional cases
of lung cancer, now giving a significant excess mortal-
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ity both for the five-year period (SMR 134, 95 010 CI
103-164) and the total study period (SMR 115, 95 %
CI 101-129), an increasing SMR with intensity of ex-
posure occurring in both the five-year and the total
study periods (SMR 359, 95 % CI131-780, and SMR
194, 95 % CI 100-339, respectively, for the high-
exposure group). However a statistical test for trend
was not significant. The increased lung cancer risk oc-
curred mainly for those employed before 1940, rising
with length of employment and also with length of
follow-up. In an examination of lung cancer mortali-
ty in relation to type of industry, the copper cadmium
alloy plants included in the study showed an excess
mortality in the five-year update (SMR 231, 95 % CI
115-413). However the pattern of mortality was deter-
mined largely by long employment in a primary pro-
duction plant, starting before 1940, but with only low
or medium exposure to cadmium.
There were 22 deaths from stomach cancer over the
five-year period (SMR 179, 95 % CI 112-271) with
98 deaths over the total study period (SMR 139,95 %
CI 111-166), seen mainly in the low-exposure category
for men employed less then 10 years.
A small, nonsignificant excess mortality was ob-
served for the category nephritis and nephrosis in the
five-year update, but not for the total study period.
There was no excess mortality from hypertensive
disease in the five-year period, with a small, nonsignifi-
cant excess for the total study period. The SMR for
cerebrovascular disease was significantly lower than
expected in both the five-year and the total study
period. Screening for the other 32 disease categories
showed a significantly low SMR for diseases of the cir-
culatory system (lCD 390-458) with an SMR of 83
(95 % CI 73-94) for the five-year period and an SMR
of 89 (95 % CI 84-94) for the total study period.
Within this broad category, ischemic heart disease
(ICD 410-414) gave SMR values of 87 (95 % CI 74
-100) for the five-year period and 92 (95 % CI 85
-98) for the total study period.
Discussion
The five-year update of the 1979 cohort study con-
firmed and strengthened the findings of the original
study with a marked excess mortality from diseases
coded as bronchitis or chronic bronchitis, which
showed a strong relationship to both intensity and
duration of exposure. As in the initial study, there were
no deaths coded as emphysema in the high- or medium-
exposure groups, but now with a significant excess
mortality in the low-exposure group. It is difficult to
interpret these emphysema deaths in relation to cad-
mium exposure, as emphysema tends to be under-
reported as an underlying cause of death in Great Bri-
tain.
With regard to cancer of the prostate, there were
again no deaths in the small high-exposure or larger
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medium-exposure groups. These findings support the
conclusion reached by Doll (2), in reviewing the
evidence following the initial study (1), that cadmium
should now cease to be regarded as a prostatic car-
cinogen. The Environmental Protection Agency in the
United States has also concluded, from a review of
existing studies, that there is insufficient evidence of
a risk of prostatic cancer from exposure to cadmium
oxide dust and fume (12).
Since the initial study, an unequivocal dose-related
increase in the incidence of primary carcinoma of the
lung has been shown in rats following the prolonged
inhalation of a cadmium chloride aerosol (9). An up-
date of a cohort study on American smeltery workers
with heavy past exposure to cadmium oxide has shown
an excess lung cancer mortality related to cumulative
exposure to cadmium, but with certain assumptions
having been made with regard to exposure to arsenic
and cigarette smoke (10). However nickel cadmium
battery workers exposed to cadmium oxide dust have
shown no clear evidence of an increased lung cancer
risk (8). In the initial cohort study, a significant ex-
cess of lung cancer deaths was shown only for men
employed more than 10 years in the always low-ex-
posure category, and it was considered unlikely that
this excess could have been related to cadmium ex-
posure. There is now a stronger indication of an ex-
cess risk from lung cancer, with a significant excess
mortality in the cohort as a whole, and also in the
small, high-exposure group. The increased risk was the
most marked for men who were first exposed before
1940, with long exposure, and who have a long period
of follow-up . However the majority of lung cancer
deaths were from a large nonferrous smeltery which
provided over 60 070 of the total study population, but
with only low or medium exposure to cadmium. In a
subsequent case-referent study in the smeltery, the ex-
cess lung cancer mortality was found to be related to
length of employment in the smeltery, but not to
cumulative exposure to cadmium (results of Ades &
Kazantzis awaiting publication). A working group on
the carcinogenicity of cadmium (14) found the epide-
miologic data on lung cancer difficult to interpret be-
cause of confounding from multiple occupational ex-
posures including other putative carcinogens and be-
cause of the difficulty with the absence of smoking
histories in assessing the contribution from cigarette
smoking. A further case-referent study of lung cancer
in workers with heavy past exposure to cadmium, tak-
ing account of concomitant exposures, is in progress.
In the initial study decedents were included below
the age of 85 years for those causes believed a priori
to be related to cadmium exposure and below the age
of 75 years in a screening procedure adopted for other
causes. An increased mortality from stomach cancer
was identified in the 1979 cohort after a reanalysis in
which a censoring age of 85 years was taken instead
of 75 years. This increased stomach cancer mortality
has been confirmed in the current update. In the five-
year period 22 additional cases of stomach cancer have
been identified, giving a significantly raised SMR of
179 for the five years and an SMR of 139 for the total
period of study. In contrast to lung cancer, however,
no relationship has been identified with intensity or
duration of exposure, the excess risk occurring in the
low-exposure group and among men with less than 10
years ' employment making it unlikely that cadmium
could have been responsible.
With regard to other diseases of interest, the small
excess mortality from hypertensive disease, which was
not statistically significant in the initial study, has re-
mained virtually unchanged, and similarly there has
been no change in the mortality pattern in the category
nephritis and nephrosis, which showed a nonsignifi-
cant deficit. However, as in the initial study, deaths
from cerebrovascular disease were significantly lower
than expected. While this finding is likely to be due
to chance, it should be noted that a low mortality from
cerebrovascular disease had previously been observed
for cadmium-polluted areas in Japan (7). Furthermore,
in a screening for 32 other causes of death, a deficit
has also been found for diseases of the circulatory
system and, within this category, for deaths from
ischemic heart disease. While the overall pattern does
not show cadmium to be a risk factor for the car-
diovascular system , these observations of a possible
reduced risk require further study.
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